Middle East & Africa Asparaginase Market Forecast to 2028

Report Code : BMIRE00027450 | Region : LAMEA | Industry : Pharmaceuticals | Published Date : 14/Nov/2022
Middle East & Africa Asparaginase Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Escherichia coli, Erwinia chrysanthemi, Pegylated, and Others), Application (Therapeutic, Food Processing, and Others), and End-use Industry (Healthcare and Food Manufacturing)

The MEA asparaginase market is expected to grow from US$ 22.60 million in 2022 to US$ 48.37 million by 2028; it is estimated to grow at a CAGR of 13.5% from 2022 to 2028.

New Product Launches and Approvals

The pharmaceutical & food industries are constantly developing at a significant rate due to the rising demand from a large population. The industries have increased new product development, product launches, and approvals across the MEA. Additionally, major market players are involved in research and development activities to ensure the innovation and development of efficient products. In recent years, the market is experiencing various developments, such as product launches and approvals, which are likely to create ample opportunities in the market. For instance, In July 2021, Ligand Pharmaceuticals Incorporated partnered with Jazz Pharmaceuticals Plc to launch Rylaze [asparaginase E. chrysanthemi (recombinant)-rywn], also known as JZP458. Rylaze is a recombinant Erwinia asparaginase used as a component of a multi-agent chemotherapeutic regimen for treating acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL) in adult and pediatric patients (1 month or older) who have developed hypersensitivity to E. coli-derived asparaginase. Similarly, in August 2020, Lonza expanded microbial capacity and extended a long-term partnership with Servier Pharmaceuticals, Inc. for l-asparaginase API manufacturing. The new facility will provide mid-scale commercial manufacturing to multiple customers and serve the growing needs of Servier, an independent international pharmaceutical company and long-term Lonza partner. Thus, the increase in new product development, launches, and other strategic collaborations among market players are likely to create ample opportunities for the asparaginase market growth in the coming years.

Market Overview

The MEA asparaginase market is segmented into the UAE, Saudi Arabia, South Africa, and Rest of MEA. Saudi Arabia dominated the market in 2022. Saudi Arabia is one of the important countries in the MEA that has significant scope for the cancer treatment market. The healthcare system in the country is developing at a rapid pace and an increasing number of international companies are developing medical and research teams in the country. Also, a sharp increase in the state health budget is expected to drive the demand for cancer drugs in the country. Saudi Arabia has a huge population base who suffer from cancer. As per the data of WHO, in 2020, approximately 27,885 new cases of cancer were registered in the country, including ~1,698 non-Hodgkin lymphoma (NHL) cases and 1,676 cases of leukemia. Moreover, a study published by King Abdul-Aziz City for Science and Technology (KACST) demonstrated that the marine environment of the Red Sea has the potential to be a potent source of bacterial strains for the discovery of anticancer drugs. The identification of strains with improved ASNase yields has attracted significant attention to improve the cost-effectiveness of these enzymes. Thus, above-mentioned factors are expected to drive the growth of asparaginase market in the coming years in the country.

MEA Asparaginase Market Revenue and Forecast to 2028 (US$ Million)

MEA Asparaginase Market Segmentation

The MEA asparaginase market is segmented based on type, application, end-use industry, and country.

Based on type, the MEA asparaginase market is segmented into escherichia coli, erwinia chrysanthemi, pegylated, and others. The escherichia coli segment held the largest market share in 2022. Based on application, the MEA asparaginase market is segmented into therapeutic, food processing, and others. The therapeutic segment held the largest market share in 2022. The therapeutic segment is further classified into acute lymphoblastic leukemia, lymphoblastic lymphoma, and others. Based on end-use industry, the MEA asparaginase market is bifurcated into healthcare and food manufacturing. The healthcare segment held the larger market share in 2022. Based on country, the MEA asparaginase market has been categorized into the UAE, Saudi Arabia, South Africa, and rest of MEA. Our regional analysis states that Saudi Arabia dominated the market in 2022. Biovendor, LLC; Creative Enzymes; Jazz Pharmaceuticals, Inc.; medac GMBH; Servier Pharmaceuticals LLC; Taj Pharmaceuticals Limited; and United Biotech (P) Limited are the leading companies operating in the MEA asparaginase market.

The List of Companies - Middle East & Africa Asparaginase Market

● Biovendor, LLC

● Creative Enzymes

● Jazz Pharmaceuticals, Inc.   

● medac GMBH    

● Servier Pharmaceuticals LLC   

● Taj Pharmaceuticals Limited    

● United Biotech (P) Limited

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Asparaginase Market – By Type

1.3.2 MEA Asparaginase Market – By Application

1.3.3 MEA Asparaginase Market – By End-Use Industry

1.3.4 MEA Asparaginase Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Asparaginase Market – Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Asparaginase Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Leukemia and Increasing Usage Application

5.1.2 Significant Growth of Pharmaceutical and Food Industry

5.2 Market Restraints

5.2.1 Side Effects Associated With Use of Asparaginase

5.3 Market Opportunities

5.3.1 New Product Launches and Approvals

5.4 Future Trends

5.4.1 Increase in R&D Activities and Investment by Market Players

5.5 Impact Analysis

6. Asparaginase Market– MEA Analysis

6.1 MEA Asparaginase Market Revenue Forecasts and Analysis

7. MEA Asparaginase Market Analysis – By Type

7.1 Overview

7.2 By Type: MEA Market Revenue and Forecast Analysis (US$ Million)

7.2.1 Escherichia Coli

7.2.1.1 Overview

7.2.1.2 Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)

7.2.2 Erwinia Chrysanthemi

7.2.2.1 Overview

7.2.2.2 Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)

7.2.3 Pegylated

7.2.3.1 Overview

7.2.3.2 Pegylated Market Revenue and Forecast to 2028 (US$ Million)

7.2.4 Others

7.2.4.1 Overview

7.2.4.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. MEA Asparaginase Market Analysis – By Application

8.1 Overview

8.2 By Application: MEA Market Revenue and Forecast Analysis (US$ Million)

8.2.1 Therapeutic

8.2.1.1 Overview

8.2.1.2 Therapeutic Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.3 Acute Lymphoblastic Leukaemia (ALL)

8.2.1.3.1 Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.4 Lymphoblastic Lymphoma (LBL)

8.2.1.4.1 Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.5 Others

8.2.1.5.1 Others Market Revenue and Forecast to 2028 (US$ Million)

8.2.2 Food Processing

8.2.2.1 Overview

8.2.2.2 Food Processing Market Revenue and Forecast to 2028 (US$ Million)

8.2.3 Others

8.2.3.1 Overview

8.2.3.2 Others Market Revenue and Forecast to 2028 (US$ Million)

9. MEA Asparaginase Market Analysis – By End-use Industry

9.1 By End-Use: MEA Market Revenue and Forecast Analysis (US$ Million)

9.1.1 Healthcare

9.1.1.1 Overview

9.1.1.2 Healthcare Market Revenue and Forecast to 2028 (US$ Million)

9.1.2 Food Manufacturing

9.1.2.1 Overview

9.1.2.2 Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

10. MEA Asparaginase Market – Country Analysis

10.1 Overview

10.1.1 MEA Asparaginase Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.1.3 Saudi Arabia: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.1.1.1.4 Saudi Arabia: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.1.1.1.4.1 Saudi Arabia: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)

10.1.1.1.5 Saudi Arabia: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)

10.1.1.2 South Africa: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 South Africa Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.2.3 South Africa: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.1.1.2.4 South Africa: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.1.1.2.4.1 South Africa: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)

10.1.1.2.5 South Africa: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)

10.1.1.3 UAE: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 UAE: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.3.3 UAE: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.1.1.3.4 UAE: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.1.1.3.4.1 UAE: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)

10.1.1.3.5 UAE: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)

10.1.1.4 Rest of Middle East and Africa: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Rest of MEA: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.4.3 Rest of MEA: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.1.1.4.4 Rest of MEA: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)

10.1.1.4.4.1 Rest of MEA: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)

10.1.1.4.5 Rest of MEA: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)

11. Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Servier Pharmaceuticals LLC

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Biovendor, LLC

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Creative Enzymes

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Taj Pharmaceuticals Limited

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 medac GMBH

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Jazz Pharmaceuticals, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 United Biotech (P) Limited

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. MEA Asparaginase Market– Revenue and Forecast to 2028 (US$ Mn)

Table 2. Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)

Table 3. Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 4. Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)

Table 5. Saudi Arabia: Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 6. South Africa Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)

Table 7. South Africa: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 8. South Africa: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)

Table 9. South Africa: Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 10. UAE: Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)

Table 11. UAE: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 12. UAE: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)

Table 13. UAE: Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 14. Rest of MEA: Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)

Table 15. Rest of MEA: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 16. Rest of MEA: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)

Table 17. Rest of MEA: Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million)

Table 18. Recent Inorganic Growth Strategies

Table 19. Recent Organic Growth Strategies

Table 20. Glossary of Terms

The List of Companies - Middle East & Africa Asparaginase Market

● Biovendor, LLC

● Creative Enzymes

● Jazz Pharmaceuticals, Inc.   

● medac GMBH    

● Servier Pharmaceuticals LLC   

● Taj Pharmaceuticals Limited    

● United Biotech (P) Limited

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA asparaginase market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the MEA asparaginase market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the asparaginase market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Middle East & Africa Asparaginase Market Forecast to 2028)
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry